Press releases

All press releases Regulatory

Press release 2020-07-03

First study group has been dosed in Xspray Pharma’s ongoing pivotal registration studies with HyNap-Dasa

Press release 2020-06-25

Xspray – Virtual Capital Markets Day today at 14.00 CET

Press release 2020-06-18

Invitation to virtual Capital Markets Day with Xspray on June 25 at 14.00-15.30 CET

Regulatory press release 2020-05-29

Xspray Pharma initiates pivotal registration studies with HyNap-Dasa for the market approval application in the United States

Regulatory press release 2020-05-14

Bulletin from the annual general meeting of Xspray Pharma AB (publ)

Press release 2020-05-14

Xspray Pharma publishes Interim report Q1, January – March 2020

Regulatory press release 2020-04-15

Xspray Pharma provides an update on how the Covid-19 pandemic affects the company’s planned clinical studies

Regulatory press release 2020-04-14

XSpray: Notice of annual general meeting of Xspray Pharma AB (publ)

Press release 2020-03-27

Trading in Xspray Pharma’s shares commences today on Nasdaq Stockholm

Press release 2020-03-26

Bulletin from the extraordinary general meeting of Xspray Pharma AB (publ)